Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Morepen Laboratories Limited ( (IN:MOREPENLAB) ) has issued an announcement.
Morepen Laboratories Limited announced that its subsidiary, Morepen Medipath Limited, has entered into a joint venture agreement with Bimedical FZE, a UAE-based entity, to form a new company focused on manufacturing, trading, and selling medical devices. This strategic move is expected to enhance Morepen’s position in the medical devices industry, potentially expanding its market reach and operational capabilities.
More about Morepen Laboratories Limited
Morepen Laboratories Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of pharmaceutical products and medical devices. The company is known for its wide range of healthcare products and has a significant presence in the medical devices sector.
Average Trading Volume: 361,152
Technical Sentiment Signal: Hold
Current Market Cap: 27.02B INR
See more insights into MOREPENLAB stock on TipRanks’ Stock Analysis page.